Castelain V - Search Results

1

Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients.

Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, Teboul JL. Mekontso-Dessap A, et al. Among authors: castelain v. Intensive Care Med. 2002 Mar;28(3):272-7. doi: 10.1007/s00134-002-1215-8. Epub 2002 Feb 8. Intensive Care Med. 2002. PMID: 11904655

2

Fusarium, Scedosporium and Other Rare Mold Invasive Infections: Over Twenty-Five-Year Experience of a European Tertiary-Care Center.

Ledoux MP, Dicop E, Sabou M, Letscher-Bru V, Castelain V, Danion F, Herbrecht R. Ledoux MP, et al. Among authors: castelain v. J Fungi (Basel). 2024 Apr 15;10(4):289. doi: 10.3390/jof10040289. J Fungi (Basel). 2024. PMID: 38667960 Free PMC article.

3

Coingestion of cyclooxygenase inhibitors can worsen severe paracetamol poisoning by middle-sized and small arteries vasoconstriction.

Schneider F, Neuville A, Meziani F, Meyer C, Assemi P, Lavigne T, Castelain V. Schneider F, et al. Among authors: castelain v. Intensive Care Med. 2003 Nov;29(11):2090-3. doi: 10.1007/s00134-003-2011-9. Epub 2003 Sep 26. Intensive Care Med. 2003. PMID: 14513213

4

Increase in plasma protein concentration for diagnosing weaning-induced pulmonary oedema.

Anguel N, Monnet X, Osman D, Castelain V, Richard C, Teboul JL. Anguel N, et al. Among authors: castelain v. Intensive Care Med. 2008 Jul;34(7):1231-8. doi: 10.1007/s00134-008-1038-3. Epub 2008 Feb 23. Intensive Care Med. 2008. PMID: 18297263 Clinical Trial.

5

Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome.

Osman D, Monnet X, Castelain V, Anguel N, Warszawski J, Teboul JL, Richard C; French Pulmonary Artery Catheter Study Group. Osman D, et al. Among authors: castelain v. Intensive Care Med. 2009 Jan;35(1):69-76. doi: 10.1007/s00134-008-1307-1. Epub 2008 Oct 7. Intensive Care Med. 2009. PMID: 18839137 Clinical Trial.

6

Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study.

Kamel T, Helms J, Janssen-Langenstein R, Kouatchet A, Guillon A, Bourenne J, Contou D, Guervilly C, Coudroy R, Hoppe MA, Lascarrou JB, Quenot JP, Colin G, Meng P, Roustan J, Cracco C, Nay MA, Boulain T; Clinical Research in Intensive Care Sepsis Group (CRICS-TRIGGERSEP). Kamel T, et al. Intensive Care Med. 2020 Mar;46(3):463-474. doi: 10.1007/s00134-019-05896-4. Epub 2020 Jan 7. Intensive Care Med. 2020. PMID: 31912201 Free PMC article.

7

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Anglés-Cano E, Sattler L, Mertes PM, Meziani F; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). Helms J, et al. Among authors: castelain v. Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4. Intensive Care Med. 2020. PMID: 32367170 Free PMC article.

8

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P; CORIMUNO-19 Collaborative Group. Hermine O, et al. JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820. JAMA Intern Med. 2021. PMID: 33080017 Free PMC article. Clinical Trial.

9

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.

COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29. Intensive Care Med. 2021. PMID: 33211135 Free PMC article.

10

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.

CORIMUNO-19 Collaborative group. CORIMUNO-19 Collaborative group. Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22. Lancet Respir Med. 2021. PMID: 33493450 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters